title: Acute coronary occlusion following TAVI.
abstract: Transcatheter aortic valve implantation (TAVI) has nowadays replaced open heart surgery as an alternative therapeutic tool in selected patients. Thirty-five percent of patients with severe degenerative aortic valve stenosis (AS) remain untreated because of the existing comorbidities that increase their perioperative risk. TAVI is a relatively new technique that has "come to stay" in the everyday clinical practice considering, that is the only alternative to surgery and appears to have excellent long term results. Herein, we describe a vascular complication immediately after the implantation of the Edwards SAPIEN (Edwards Lifesciences, Irvine, CA) prosthesis, followed by ad hoc percutaneous coronary intervention.
authors.affiliation: Second Department of Cardiology, Laboratory of Cardiac Catheterization and Intervention, University Hospital ATTIKON, Athens, Greece. b.gogas@erasmusmc.nl
authors.forename: Bill D
authors.initials: BD
authors.lastname: Gogas
authors.forename: Achilleas A
authors.initials: AA
authors.lastname: Zacharoulis
authors.forename: Aias G
authors.initials: AG
authors.lastname: Antoniadis
mesh_terms: D000208:Acute Disease; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation; D001024:Aortic Valve Stenosis / Q000628:therapy*; D006328:Cardiac Catheterization / Q000009:adverse effects* / Q000295:instrumentation; D017023:Coronary Angiography; D054059:Coronary Occlusion / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D005260:Female; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation; D006801:Humans; D008875:Middle Aged; D011474:Prosthesis Design; D015607:Stents; D016896:Treatment Outcome